Special studies/analysis- chemical/biological
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- HHSN261201500009I
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5 Part of Irisys, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 40 $5,220,020 obligated
Award facts
- Opportunity
-
- N02CM5700205 Solicitation number
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jul 6, 2015
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jan 6, 2015
- Combined order value
-
- $5,220,020 Current, with exercised options
- $8,900,698 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 87% used
- $6,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
Societal Cdmo San Diego, LLC, a small disadvantaged business and subsidiary of Irisys, Inc., was awarded an Indefinite Delivery Contract by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract, valued up to $6 million, is for the SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL services to support the NCI's cancer research and drug development programs.
Under this Indefinite Delivery Contract, Societal Cdmo San Diego has received numerous task orders to provide a range of pharmaceutical development, manufacturing, and testing services for the NCI and other NIH components. These services include the production of oral capsules, injectable solutions, and nasal sprays for investigational new drugs and clinical trials related to oncology, neurology, addiction, and rare diseases. Specific projects have involved the manufacture of compounds such as metarrestin, z-endoxifen, AZA-TDC, TAK-243, and imiquimod cream. Societal Cdmo San Diego also conducts stability studies, shelf-life assessments, and analytical testing for these drug products at its facilities in San Diego, California. No set-aside designations were applied to the Indefinite Delivery Contract or associated task orders.
Task orders
Show all 40
Transactions
| Action | Obligated | Date |
|---|---|---|
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201500009I?
HHSN261201500009I was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on June 30, 2015.
How much is contract HHSN261201500009I worth?
Orders under HHSN261201500009I have obligated $5,220,020. Their combined potential value, with all options, is $8,900,698. HHSN261201500009I's own ceiling is $6,000,000.
How many orders have been placed under contract HHSN261201500009I?
40 orders have been placed under HHSN261201500009I, the latest on May 8, 2020.
Who can order from contract HHSN261201500009I?
HHSN261201500009I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HHSN261201500009I competed?
The extent of competition for HHSN261201500009I was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV